Istiratumab
- Generic Name
- Istiratumab
- Drug Type
- Biotech
- CAS Number
- 1509928-04-4
- Unique Ingredient Identifier
- XLR461MD3M
- Background
Istiratumab is under investigation in clinical trial NCT02399137 (A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath